4-chloro-1,8-naphthosultam | 4709-24-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 4-chloro-1,8-naphthosultam
• 英文别名: 5-chloro-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide；5-chloronaphtho[1,8-cd]isothiazole 1,1-dioxide；4-Chlor-1,8-naphthosulfam；7-chloro-2λ6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4(12),5,7,9-pentaene 2,2-dioxide
• CAS: 4709-24-4
• 化学式: C₁₀H₆ClNO₂S
• 分子量: 239.682
• InChiKey: XPOSZKJUFRVQCY-UHFFFAOYSA-N

物化性质

• 熔点：
  201-202 °C
• 沸点：
  465.2±47.0 °C(Predicted)
• 密度：
  1.603±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-chloro-1,8-naphthosultam 在 sodium acetate 、 锌 作用下， 以 乙醇 、 溶剂黄146 为溶剂， 反应 2.0h， 生成 5-Chloro-1,1-dioxo-1,2-dihydro-1λ⁶-naphtho[1,8-cd]isothiazol-3-ylamine
  参考文献：
  名称：

  Hammouda, Hamdy A.; El-Reedy, Ahmed M.; Sharaf, Mohie A. F., Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 337 - 339

  摘要：

  DOI：
• 作为产物：
  描述：

  2-乙酰基-2H-萘并[1,8-cd]异噻唑1,1-二氧化物 在 sodium hydroxide 、 氯 作用下， 以 溶剂黄146 为溶剂， 生成 4-chloro-1,8-naphthosultam
  参考文献：
  名称：

  1,8-萘舒坦及其取代衍生物的研究（舒坦化学，III）

  摘要：

  4-氯-1,8-萘舒坦是通过氯化N-乙酰基-1,8-萘舒坦和随后水解获得的。1,8-萘舒坦与溴化碘的溴化主要产生4-溴衍生物。通过用一氯化碘处理 1,8-萘舒坦或其 N-取代衍生物，很容易实现 4-位碘的取代。

  DOI：

  10.1002/ardp.19652981103

文献信息

• Derivatives of (AZA)naphthalenesultam, their preparation and
  申请人：Rhone-Poulenc Sante

  公开号：US05021420A1

  公开（公告）日：1991-06-04

  This invention relates to a compound ##STR1## in which R.sub.1 represents a 1,2,3,6-tetrahydro-1-pyridyl radical substituted in the 4-position by (a) a phenyl radical, (b) a phenyl radical substituted by a halogen atom or an alkyl, hydroxy or alkoxy radical, (c) a 3-indolyl radical, (d) a 3-indolyl radical substituted on the nitrogen atom by an alkyl or alkylcarbonyl radical and/or in the 5-position by a halogen atom or (e) a 3-(5-hydroxyindolyl) radical. a 1-piperazinyl radical substituted in the 4-position by (a) a phenyl radical, (b) a phenyl radical substituted by an alkoxy, alkyl, hydroxy, nitro or amino radical or a halogen atom, (c) a 1,2-benzisothiazol-3-yl radical, (d) a 1,2-benzisoxazol-3-yl radical or (e) a 2-pyridyl radical. a piperidino radical substituted in the 4-position by (a) a phenyl radical, (b) a phenyl radical substituted by a halogen atom or a hydroxy, alkyl or alkoxy radical, (c) two phenyl radicals, (d) a bis(4-fluorophenyl)methylene radical, (e) a 4-fluorobenzoyl radical, (f) a 2-oxo-1-benzimidazolinyl radical, (g) a 2-oxo-1-benzimidazolinyl radical substituted in the 3-position by an alkylcarbonyl or benzoyl radical, (b) a hydroxy radical and a phenyl radical optionally substituted with an alkyl, alkoxy or hydroxy radical or a halogen atom, (i) a 3-indolyl radical, (j) a 3-indolyl radical substituted on the nitrogen atom by an alkyl or alkylcarbonyl radical and/or in the 5-position by a halogen atom or (k) a 3-(5-hydroxyindolyl) radical. either: R.sub.2 and R.sub.3, which are identical, represent a hydrogen or halogen atom and R.sub.4 represents a hydrogen atom or R.sub.2 and R.sub.4 represent a hydrogen atom and R.sub.3 represents a halogen atom or an acetylamino radical or R.sub.2 and R.sub.3 represent a hydrogen atom and R.sub.4 represents a halogen atom and R.sub.5 represents a --CH.dbd. group. or R.sub.2, R.sub.3 and R.sub.4 represent a hydrogen atom and R.sub.5 represents a nitrogen atom. R.sub.6 represents an alkylene chain containing 2 to 4 carbon atoms or a propylene chain substituted in the 1- or 3-position by an alkyl radical or in the 2-position by an alkyl, alkoxy, hydroxy, dialkylamino, piperidino, morpholino or thiomorpholino radical, with the reservation that when R.sub.6 represents a propylene radical substituted in the 2-position by a dialkylamino, piperidino, morpholino or thiomorpholino radical, R.sub.1 cannot be a radical containing a hydroxy radical, and their salts, are useful in therapy for their ability to block serotonin receptors.

  本发明涉及一种化合物##STR1##在该化合物中，R.sub.1代表在4位被(a)苯基取代的1,2,3,6-四氢-1-吡啶基基团，(b)被卤原子或烷基、羟基或烷氧基取代的苯基，(c)3-吲哚基，(d)氮原子上被烷基或烷基羰基基团取代和/或在5位被卤原子取代的3-吲哚基，或(e)3-(5-羟基吲哚基)基团；在4位被(a)苯基，(b)被烷氧基、烷基、羟基、硝基或氨基取代的苯基，或卤原子取代的苯基，(c)1,2-苯并噻唑-3-基团，(d)1,2-苯并噁唑-3-基团或(e)2-吡啶基取代的1-哌嗪基团；在4位被(a)苯基，(b)被卤原子或羟基、烷基或烷氧基取代的苯基，(c)两个苯基，(d)双(4-氟苯基)甲基基团，(e)4-氟苯甲酰基团，(f)2-氧代-1-苯并咪唑啉基团，(g)在3位被烷基羰基或苯甲酰基团取代的2-氧代-1-苯并咪唑啉基团，(b)羟基和苯基，后者可选地被烷基、烷氧基或羟基或卤原子取代，(i)3-吲哚基，(j)氮原子上被烷基或烷基羰基基团取代和/或在5位被卤原子取代的3-吲哚基，或(k)3-(5-羟基吲哚基)基团；或者：R.sub.2和R.sub.3，它们相同，代表氢或卤原子，R.sub.4代表氢原子，或R.sub.2和R.sub.4代表氢原子，R.sub.3代表卤原子或乙酰氨基基团，或R.sub.2和R.sub.3代表氢原子，R.sub.4代表卤原子，R.sub.5代表-CH.dbd.基团。或R.sub.2，R.sub.3和R.sub.4代表氢原子，R.sub.5代表氮原子。R.sub.6代表含有2到4个碳原子的烷基链或在1位或3位被烷基基团取代的丙烯基链，或在2位被烷基、烷氧基、羟基、二烷基氨基、哌啶基、吗啉基或硫代吗啉基团取代的丙烯基链，但是当R.sub.6代表在2位被二烷基氨基、哌啶基、吗啉基或硫代吗啉基团取代的丙烯基时，R.sub.1不能是含有羟基团的基团，它们的盐，因其阻断5-羟色胺受体的能力，在治疗中具有用途。
• Derivatives of (AZA) naphthalensultam, their preparation and
  申请人：Rhone-Poulenc Sante

  公开号：US05036075A1

  公开（公告）日：1991-07-30

  This invention relates to a compound of the formula: ##STR1## in which R.sub.1 represents a 1,2,3,6-tetrahydro-1-pyridyl radical substituted in the 4-position. a 1-piperazinyl radical substituted in the 4-position. a piperidino radical substituted in the 4-position either: R.sub.2 and R.sub.3, which are identical, represent a hydrogen or halogen atom and R.sub.4 represents a hydrogen atom or R.sub.2 and R.sub.4 represent a hydrogen atom and R.sub.3 represents a halogen atom or an acetylamino radical or R.sub.2 and R.sub.3 represent a hydrogen atom and R.sub.4 represents a halogen atom and R.sub.5 represents a --CH.dbd. group. or R.sub.2, R.sub.3 and R.sub.4 represent a hydrogen atom and R.sub.5 represents a nitrogen atom. R.sub.6 represents an alkylene chain containing 2 to 4 carbon atoms or a propylene chain substituted in the 1- or 3-position by an alkyl radical or in the 2-position by an alkyl, alkoxy, hydroxy, dialkylamino, piperidino, morpholino or thiomorpholino radical, and their salts, are useful in therapy for their ability to block serotonin receptors.

  本发明涉及一种式为：##STR1##其中R.sub.1代表在4位取代的1,2,3,6-四氢-1-吡啶基基团，4位取代的1-哌嗪基基团或4位取代的哌啶基基团，其中：R.sub.2和R.sub.3相同，代表氢或卤素原子，R.sub.4代表氢原子，或R.sub.2和R.sub.4代表氢原子，R.sub.3代表卤素原子或乙酰氨基基团，或R.sub.2和R.sub.3代表氢原子，R.sub.4代表卤素原子，R.sub.5代表--CH.dbd.基团，或R.sub.2、R.sub.3和R.sub.4代表氢原子，R.sub.5代表氮原子。R.sub.6代表含有2至4个碳原子的烷基链或在1-或3-位被烷基基团取代的丙烯基链，或在2-位被烷基、烷氧基、羟基、二烷基氨基基团、哌啶基、吗啉基或硫代吗啉基取代的丙烯基链，以及它们的盐，用于治疗因其阻断5-羟色胺受体的能力而具有的功效。
• COMTE, MARIE-THERESE;MALLERON, JEAN-LUC;PEYRONEL, JEAN-FRANCOIS;TRUCHON, +
  作者：COMTE, MARIE-THERESE、MALLERON, JEAN-LUC、PEYRONEL, JEAN-FRANCOIS、TRUCHON, +

  DOI：——

  日期：——
• US5021420A
  申请人：——

  公开号：US5021420A

  公开（公告）日：1991-06-04
• US5036075A
  申请人：——

  公开号：US5036075A

  公开（公告）日：1991-07-30